| Stage | Morphology | Staining | Recurrence Risk | Management |
|---|---|---|---|---|
| Epithelial (Primary) | Dendritic ulcer with terminal bulbae | Fluorescein (ulcer base), rose bengal (infected cells) | Yes (40–50% recur) | Topical antivirals (acyclovir, ganciclovir) |
| Stromal (Recurrent) | Disciform infiltration, Descemet's folds, endotheliitis | Minimal fluorescein uptake | Yes | Topical + systemic antivirals + topical steroids |
| Endotheliitis (Immune) | Keratic precipitates, anterior chamber reaction | Minimal epithelial staining | Yes | Topical steroids + antivirals |
Loading illustration…
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →